FDA Clears First AI Tool to Predict Risk from a Mammogram
The U.S. Food and Drug Administration (FDA) has granted De Novo authorization to Clairity Breast, the first-ever AI-powered platform that predicts a woman’s risk of developing breast cancer over the next five years—using only a standard mammogram.
Read more
